Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angels Sierra

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 24, 2024
Suppression of metastatic organ colonization and antiangiogenic activity of the orally bioavailable lipid raft-targeted alkylphospholipid edelfosineVerónica Alonso-Pérez, Vanessa Hernández, Marco A Calzado, et al.
Frontiers in Oncology|December 19, 2017
Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to ProphylaxisAntonio Martínez-Aranda, Vanessa Hernández, Ferran Moreno, et al.
Molecular & Cellular Proteomics : MCP|April 30, 2013
A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasisNaiara Santana-Codina, Rafael Carretero, Rebeca Sanz-Pamplona, et al.
Neuro-Oncology|October 23, 2019
GRP94 promotes brain metastasis by engaging pro-survival autophagyNaiara Santana-Codina, Laia Muixí, Ruben Foj, et al.
The American Journal of Pathology|June 29, 2011
Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumorsRebeca Sanz-Pamplona, Ramón Aragüés, Keltouma Driouch, et al.
Journal of Clinical Immunology|May 27, 2025
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 SeverityArnau Antolí, Gardenia Vargas-Parra, Angels Sierra-Fortuny, et al.
Oncotarget|October 27, 2015
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategiesAntonio Martínez-Aranda, Vanessa Hernández, Emre Guney, et al.
Cancer Research|August 5, 2008
A six-gene signature predicting breast cancer lung metastasisThomas Landemaine, Amanda Jackson, Akeila Bellahcène, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2025
Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patientsArnau Antolí, José Luis Gómez-Vázquez, Angels Sierra-Fortuny, et al.
EMBO Molecular Medicine|March 7, 2023
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancerMarina Ciscar, Eva M Trinidad, Gema Perez-Chacon, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 24, 2024
Suppression of metastatic organ colonization and antiangiogenic activity of the orally bioavailable lipid raft-targeted alkylphospholipid edelfosineVerónica Alonso-Pérez, Vanessa Hernández, Marco A Calzado, et al.
Frontiers in Oncology|December 19, 2017
Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to ProphylaxisAntonio Martínez-Aranda, Vanessa Hernández, Ferran Moreno, et al.
Molecular & Cellular Proteomics : MCP|April 30, 2013
A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasisNaiara Santana-Codina, Rafael Carretero, Rebeca Sanz-Pamplona, et al.
Neuro-Oncology|October 23, 2019
GRP94 promotes brain metastasis by engaging pro-survival autophagyNaiara Santana-Codina, Laia Muixí, Ruben Foj, et al.
The American Journal of Pathology|June 29, 2011
Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumorsRebeca Sanz-Pamplona, Ramón Aragüés, Keltouma Driouch, et al.
Journal of Clinical Immunology|May 27, 2025
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 SeverityArnau Antolí, Gardenia Vargas-Parra, Angels Sierra-Fortuny, et al.
Oncotarget|October 27, 2015
FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategiesAntonio Martínez-Aranda, Vanessa Hernández, Emre Guney, et al.
Cancer Research|August 5, 2008
A six-gene signature predicting breast cancer lung metastasisThomas Landemaine, Amanda Jackson, Akeila Bellahcène, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2025
Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patientsArnau Antolí, José Luis Gómez-Vázquez, Angels Sierra-Fortuny, et al.
EMBO Molecular Medicine|March 7, 2023
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancerMarina Ciscar, Eva M Trinidad, Gema Perez-Chacon, et al.
Pageof 3